Title: The new name for
1Alistair Milne Cass Business School amilne_at_city.ac
.uk Risk Management in Insurance and
Insolvency, The Hebrew University of
Jerusalem, October 16th-17th 2006
2 Economic and Regulatory Capital Applications
in Banking and Lessons for the Insurance Industry
Alistair MilneCass Business School
3My research focus
- bank capital and shareholder value
- i.e. risk-management and corporate finance
- co-authors and papers
- Giles and Milne (2004)
- Dimou, Lawrence, and Milne (2005)
- Milne and Onorato (2006a,2006b)
- Milne (2006) Three lessons
- theory informed by extensive interaction with
practitioners -
4Agenda for today
- The rise of bank risk management
- bank economic capital current practice
- A critique of this thinking
- Practical issues
- Cost of regulatory capital requirements
- Skewness
- Two proposed performance measures
- Implications for insurance industry
5Rise of bank risk-management
6Greater competition
- Core business (retail deposits, lending to
households and smaller
business) remains profitable but - Narrower margins in many markets
- Especially corporate sovereign
- New products creating exposure to
market risks
7Governance centre stage
- Larger, more complex, institutions
- Less state ownership or support more answerable
to shareholders - Pressure to increase shareholder returns
- Greater regulatory freedom in choice of
activities - Regulatory oversight of risk-management
8Databases and modelling
- Cost of collecting, storing, and manipulating
data fallen dramatically - New tools
- Market risk VaR
- Portfolio models of corporate and sovereign
credit risks - Search for enterprise wide measures of risk/
return e.g. pricing tools
9Bank economic capitalcurrent practice
10A new language
- Capital
- Capital as a measures of worst case exposure
- Eg value at risk
- Efficient allocation of this capital, to
activities earning the highest return - Two birds with one stone
- Solvency (enough capital) and
- risk-reward tradeoffs (efficient allocation of
capital)
11RAROC
- Standard formulation
- Economic Capital value at risk type measure
to cover all risks (market, credit, operational) - Accept when RAROC exceeds hurdle
- Widely used, especially in trading floors and
corporate lending
12RAROC Logic
- Equity capital to maintain AA rating, commonly
99.97 on one year horizon - average AA default frequency
- By assumption economic prudential
- Equity capital is in limited supply
- ration according to rate of return
- Hurdle rate sometimes related to return on
equity
13Regulatory dimension
- approved internal models for setting regulatory
requirements on trading book, since 1996 - Basel II aims to align regulatory and economic
capital - Concerns about regulatory arbitrage
- EU implementation 2007, delayed in US
- IRB model based calculations of credit risk
- not based on portfolio models, but asks banks to
compute PD, LGD as inputs, and these could be
derived from same databases as a portfolio model
14A critique
15A critique
- Practical problems
- Cost of regulatory capital?
- Skewness
- Conclusions use alternative performance measures,
distinguish tail risks and risk-return tradeoffs
16Competitive advantage?
- Proposition 1 lower regulatory capital provides
me with a competitive advantage - Proposition 2 estimating tail risks and
allocating economic capital provides me with a
competitive advantage - Both must be qualified
- Competitive advantage of regulatory capital is
small - Tail risks relatively unimportant to pricing
- focus on value creation
- Requires different metrics than RAROC
171. Some practical issues
18Data problems credit risk
- Larger corporates/ sovereigns fairly OK
- CreditMetrics/MKMV
- US ratings history back to 1950s or earlier
- Difficulties with LGD
- Retail (including smaller corporates)
- a variety of scoring models, good for PD
- a little work on CVaR
- best UK institutions around 10-12 years data
- UK FSA transitional arrangements accept 5 years
of data for Basel computations! 2 years for LGD - Other low default portfolios,
- even more severe data problems
- Correlations?
19Data problems op risk
- Even greater than for credit risk
- High frequency/ low impact
- Most firms have databases, for a few years
- Little comparability between firms
- Mostly EL (minor contribution to EC)
- Low frequency/ high impact
- By their nature no data
- Low correlation with market/ credit risks?
20Outcome
- lacking data we extrapolate
- standard deviations, using arbitrary multipliers
- PD as in Basel risk curves (Vasicek single factor
model plus arbitrary correlation loading) - OP risk low frequency high impact, no
statistical basis at all - We are confusing
- Risk/return tradeoff (does not need extreme tail)
- prudential safety (cannot be based on statistical
models)
21RAROC difficulty (1)
- Liquidity facilities
- eg Lines of credit to a AAA/AA corporates
- eg commercial paper underwriting
- Must back with capital
- to maintain liquidity over (say) 24 months
- Loss v. unlikely 99.97 appropriate
- So VERY safe lending
- 15 required return on this committed capital
leads to unreasonably high pricing - Cannot compete with market prices
22 RAROC difficulty (2)
- Capital in trading operations
- Liquidity is lifeblood, need to survive
temporary market fluctuations without being
forced to close positions - Well known examples LTCM, Metallgesellschaft
- Investors (shareholders) need to distinguish
extreme tails and normal range of market
fluctuations, only latter is priced risk
23Back to basics
- Ultimate objective shareholder value
- Appropriate trade-offs between risk and reward
- Protecting solvency of the institution
- Incentives for employees and line management
- Well developed tools for these tasks for
non-financial companies - Net Present Value (NPV)
- Economic Value Added
- So lets apply these tools to banks
24Some findings
- Regulatory capital is NOT expensive
- RAROC can be a misleading measure of returns to
shareholders - In order to create shareholder value..
- Distinguish capital management (liquidity,
solvency) and risk-return tradeoffs - Modelling should take a back seat, to business
application and organisational credibility
252. The cost of regulatory capital
26Basic argument
- WACC weighted average cost of capital
- Sum of debt and equity components
- Changing reg cap only small change WACC
- linked to Modigliani-Miller (1958)
- Detail (Milne and Giles (2004))
- Equity capital small proportion of total funding
- regulatory capital lt 11 impact on equity capital
- e.g. if following rating agency target
- Leverage adjustment
- Higher equity capital makes equity capital less
risky, lowers cost of equity
27(No Transcript)
28Cost of regulatory capital?
- Even without leverage adjustment, regulatory
capital not very expensive - WACC then yields an upper bound
- Financial Services Authority calculations
- eg Basel II, reduces reg cap by 10, worth at
most 3 basis points on cost of funding your loan
portfolio - Some implications
- regulatory capital driven securitisation destroys
shareholder value - Basel Pillar 1 calculations not of great business
importance
29Dimou, Lawrence, Milne (2005)
- Increases tax exposure
- higher equity capital reduces tax shield
- a transfer a private but NOT a social cost
- Reduces access to bank safety net
- Higher equity capital forces bank owners to
accept more risk - a transfer a private but NOT a social cost
- Lowers expected costs of bankruptcy
- Higher capital reduces probability of bankruptcy/
financial distress - a benefit Social benefits likely to exceed
private benefits. - Agency costs
- Bank managers look after themselves, not
shareholders - Equity capital gives managers freedom to pursue
their own ends - Reg cap is different, it is a discipline on
managers just like debt - neutral No private cost of reg cap, if not used
as risk measure
303. Skewness
31Theory
- Proposition 1 (Onorato-Milne (2006))
- Economic capital prudential capital
- iff insurance cost of hedging risk w is
proportional to prudential tail H-1(w) - Corollary
- RAROC hurdle delivers shareholder value if all
risk distributions have the same skew - Turnbull-Crouhy-Wakeman (1999) special case
- Log normal asset returns so (right) skew
increasing with s - As s rises, prudential tail rises less than
insurance cost - So RAROC threshold rises with s
32Illustrations
- Taken from Milne and Onorato (2006a)
- Apples and Pears? The comparison of bank
economic and prudential capital. - Assume market price of risk proportional to
standard deviation - Compare symmetric and right-tailed returns
- What then is NPV0 hurdle rate for RAROC?
33(No Transcript)
34A credit risk distribution
- Credit risk left skew
- Vasicek asymptotic single factor model
- Model used for Basel IRB risk curves
- Left skew , so smaller NPV 0 RAROC
- More detail on parameters
- PD probability of default
- ? correlation of credit risk driver with market
- R2 correlation with aggregate (systematic) risk
- How do these parameters affect RAROC hurdle?
35(No Transcript)
36Critique summarised
- Two different objectives
- Prudential (avoiding financial distress,
satisfying regulator) - Risk-return tradeoffs
- Using one measure of capital for both purposes
creates conflicts - If tail risk is uncertain
- If tail risk is skewed
- If regulators take a conservative view of risks
- Again does not matter to the business
37Two proposed performance measures
38Proposed measures
- Milne and Onorato (2006a) discount with market
based risk-premium f - Milne and Onorato (2006b) use Wang transform
39More theory
- Inventory models
- Incorporate costs of financial distress, or
penalty costs of raising capital - Froot and Stein (1998), Milne (2004)
- Outcome additional internal beta G
- Measures the risk of capital shortage
- Depends upon
- Probability of capital shortage
- Costs of financial distress
- For well capitalised bank, G can be ignored
- Probability of capital shortage is negligible
40Implication
- Longer term equity capital not constrained
- Retain earnings or rights issue
- No need to ration, adjust to minimise WACC
- Measuring NPV (shareholder value)
- right WACC input
- e.g. betas (cost of risk)
- depend on correlation with market NOT with
balance sheet - Equivalent to cost of insuring exposure
- Capital constrained?
- Additional cost of risk internal or portfolio
beta G, for rationing capital
41With market prices for risk
- If risk can be priced on market, proceed as
follows (Milne and Onorato (2006a)) - Discount future returns with risk-premium taken
from market prices - equivalently estimate the cost of hedging
completely on the market and deduct this cost
from expected return - (risk neutral pricing)
- Divide by contribution to prudential capital
- Hurdle rate? Zero if unconstrained. Otherwise
chosen to ration equity capital
42No market prices for risk
- Use distortion measure (Milne and Onorato
(2006b )) eg Wang transform - Portfolio based
- Satisfies axioms of coherence and second order
stochastic dominance - Divide by contribution to prudential capital
- Hurdle rate? Zero if unconstrained. Otherwise
chosen to ration equity capital
43Merits of Wang transform
- Yields an expected value
- Analagous to risk neutral pricing distort
the probability density of returns - risk appetive can be parameterized using a
single parameter p
44In practice very limited data
- Especially for tail risks
- Sophisticated modellign of tail risks not ormally
appropraite - Simple stress or scenario analysis
- Aim to achieve credibility, within the
organisation and also with shareholders.
45Implications for insurance
- Some preliminary thoughts open to discussion
- First general insurance, then life
46When re-insurance markets available
- Logic of Milne and Onorato (2006a) applies.
- Price risk according to what it would cost to
transfer onto re-insurance market deduct from
premium income - Set a hurdle rate cost of equity capital
- Zero if unconstrained, gt zero if rationing
47When reinsurance limited
- Use of the Wang transform can help systematise
thinking about risk-appetite - Needs to be supplemented by e.g. stressed
scenarios, to check capital adequacy
48Data sometimes available
- For some products extensive data available
- Also the products where reinsurance markets are
most liquidy - Models can be used for computing capital, but
pricing best done off the market - For other products, very limited data and
illiquid markets for re-insurance. - Here focus on the simplest possible modelling
tools
49One difference insurance and banking -
segmentation
- Banks all seek to maintain high credit ratings
- Some insurers may opt for lower capitalisation,
and lower premium pricing to customers, with the
understanding that they may fail in the event of
a large aggregate rise in claims - Customers carry aggregate tail risks
- Other insurers may choose high capitalisation,
high pricing
50Life insurance
- Very long term mortality risks
- No possibility of precise quanitification
- Operate with conservative capitalisation
- Should not restrict business, provided need for
capital is understood by sharholders
51Summary
52I have discussed
- The rise of bank risk management
- bank economic capital current practice
- A critique of this thinking
- Practical issues
- Cost of regulatory capital requirements
- Skewness
- Two proposed performance measures
- Implications for insurance industry
53Some findings
- Regulatory capital is NOT expensive
- RAROC can be a misleading measure of returns to
shareholders - In order to create shareholder value..
- Distinguish capital management (liquidity,
solvency) and risk-return tradeoffs - Modelling should take a back seat, to business
application and credibility in the organisation - Similar issues in insurance no problem with
conservative capitalisation
54Priority better risk language
- Simple enough to be understood throughout the
organisation - Key concepts
- Balance sheet commitment and liquidity
- Not a pricing issue
- Expected loss
- Cost of carrying risk
- What reward do shareholders require for holding
risk? - Use models where appropriate (market risk,
corporate credit risk, retail insurance)